Medical Marijuana

    Cannabis and Glaucoma: Why Ophthalmologists Say No

    Last updated: 4 min read
    Eye examination measuring intraocular pressure in a glaucoma patient
    A real effect that is too short-lived to be a treatment.

    Cannabis and glaucoma is one of the oldest claims in medical cannabis, and it comes from a real finding. Research in the 1970s established that THC lowers intraocular pressure, and elevated intraocular pressure is the main modifiable risk factor in glaucoma.

    So the mechanism is real. Despite that, the American Academy of Ophthalmology does not recommend cannabis for glaucoma, and that position is not obstinacy. Work through the numbers and you reach the same conclusion.

    What Cannabis Actually Does to Eye Pressure

    THC reduces intraocular pressure by roughly 25 percent, and the effect lasts about three to four hours.

    Both halves matter. A 25 percent reduction is clinically meaningful, comparable in size to some prescribed medications. Three to four hours is the problem.

    The Arithmetic That Kills It

    Glaucoma damages the optic nerve continuously. Treatment has to hold pressure down around the clock, not for part of the day. If a dose lasts four hours, maintaining control requires six to eight doses every day, indefinitely.

    That means being intoxicated for essentially all waking hours, forever. Consider what that entails: no driving, cognitive impairment throughout, a substantial daily inhaled or ingested load, tolerance developing over time, and dependence.

    Meanwhile prescription eye drops control pressure with one or two daily applications, act locally with minimal systemic effect, and come in several classes that can be combined. Surgical and laser options exist for cases drops cannot manage.

    Nobody rejects cannabis here because they doubt the effect. They reject it because six to eight intoxicating doses a day is a worse treatment than a drop in each eye morning and night.

    The Blood Pressure Problem

    There is a second concern, and it is more serious than the inconvenience argument.

    Cannabis lowers systemic blood pressure. The optic nerve depends on adequate ocular perfusion pressure, roughly the difference between blood pressure supplying the eye and the intraocular pressure pushing back. Reduced blood flow to the optic nerve is itself implicated in glaucomatous damage.

    So cannabis may lower intraocular pressure while simultaneously lowering the blood pressure that perfuses the nerve you are trying to protect. The net effect on the nerve is not established, and it is at least possible that it works against the goal. That possibility is a large part of why ophthalmologists are unwilling to endorse it.

    Why Eye Drops Made From Cannabinoids Have Not Worked

    The obvious fix would be a topical cannabinoid, giving local pressure reduction without intoxication or systemic blood pressure effects. Researchers have tried.

    The obstacle is chemistry. Cannabinoids are highly lipophilic and poorly water soluble, which makes them difficult to formulate into an aqueous eye drop that penetrates the cornea at a useful concentration. Attempts have run into irritation and inadequate absorption. Work on formulation continues, and it remains the most plausible route to a legitimate cannabinoid glaucoma therapy, but nothing has reached approval.

    Where the Receptors Are

    CB1 receptors are present in ocular tissue including the ciliary body and trabecular meshwork, the structures that produce and drain aqueous humour. That anatomy is why the pressure effect exists at all and why the topical idea is reasonable in principle.

    Other Eye Effects Worth Knowing

  1. Red eyes come from vasodilation of conjunctival blood vessels. Cosmetic, harmless, and unrelated to pressure.
  2. Dry eye. Cannabis can reduce tear production, which matters for anyone already using preserved eye drops several times a day, since dry eye and glaucoma treatment frequently coexist.
  3. Retinal and diabetic eye research. Cannabinoids have been examined in preclinical work for neuroprotection relevant to retinal disease and diabetic retinopathy. This is early-stage laboratory research, not a treatment option, and it should not be presented as one.
  4. If You Have Glaucoma and Use Cannabis

    Three things are worth doing:

    1. Tell your ophthalmologist. Not for a lecture, but because cannabis affects blood pressure and can interact with other medications, and they are tracking your pressure over time. 2. Do not substitute it for prescribed treatment. Glaucoma damage is irreversible. Vision lost to inadequately controlled pressure does not come back, and the disease is often symptomless until damage is advanced. 3. Keep your appointments. Pressure control is verified by measurement, not by how your eyes feel.

    Bottom Line

    Cannabis lowers eye pressure by about 25 percent for three to four hours, which would require six to eight intoxicating doses daily to control a 24-hour disease. It may also reduce blood flow to the optic nerve. Prescription drops do the job better with one or two doses and no impairment. The pharmacology is real, the treatment is not.

    Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making any health-related decisions.

    Frequently Asked Questions

    Does cannabis lower eye pressure?

    Yes. THC reduces intraocular pressure by roughly 25 percent, a reduction comparable to some prescribed medications. The effect lasts only about three to four hours, which is the reason it does not work as a treatment for a disease that needs round-the-clock control.

    Why do eye doctors advise against cannabis for glaucoma?

    Because the effect lasts three to four hours, controlling pressure would take six to eight intoxicating doses every day indefinitely. Cannabis also lowers systemic blood pressure, which may reduce perfusion of the optic nerve it is meant to protect. Prescription drops work with one or two daily doses and no impairment.

    Are there cannabinoid eye drops for glaucoma?

    None approved. Cannabinoids are highly lipophilic and poorly water soluble, which makes formulating an eye drop that penetrates the cornea at a useful concentration difficult, and attempts have run into irritation and poor absorption. It remains the most plausible route to a legitimate cannabinoid therapy here.

    Can I use cannabis alongside my glaucoma medication?

    Discuss it with your ophthalmologist rather than deciding alone, because cannabis affects blood pressure and can interact with other medicines. Do not substitute it for prescribed treatment. Glaucoma damage is permanent and the disease is often symptomless until vision loss is advanced.

    Share this article

    Further Reading